Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2012

Sep 21, 2012

29777_dirs_2012-09-21_d6043c2c-d2a2-41e4-8dfa-d3dace0fb0dc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2012-09-20

Reporting Person: ALBAN CARLOS (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-09-20 Common shares without par value M 1918 $56.98 Acquired 116735 Direct
2012-09-20 Common shares without par value S 1918 $69.75 Disposed 114817 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-09-20 Option (right to buy) $56.98 M 1918 Disposed 2014-02-19 Common shares (1918) Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.